Kenneth Muckala
Family Medicine · Tulsa, OKNPI 1649233321
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $599 and has fallen 97.7% since, to $14 in 2024.
Across 139 payments — averaging $15.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$322
- Mylan Specialty L.p.$305
- Daiichi Sankyo Inc.$292
- Amarin Pharma, Inc.$232
- AstraZeneca$170
- Merck$86
- plus $708 from 19 others
What the payments were for
- Food & beverage$2,115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $322 |
| Mylan Specialty L.p. | 19 | $305 |
| Daiichi Sankyo Inc. | 17 | $292 |
| Amarin Pharma, Inc. | 16 | $232 |
| AstraZeneca | 8 | $170 |
| Merck | 7 | $86 |
| Lilly USA, LLC | 6 | $85 |
| Novo Nordisk | 4 | $71 |
| AbbVie | 4 | $67 |
| Boehringer Ingelheim | 5 | $63 |
| Biohaven Pharmaceuticals, Inc. | 4 | $54 |
| Astellas Pharma US Inc | 4 | $53 |
| Amgen(2 entities) | 3 | $43 |
| Medtronic(2 entities) | 3 | $41 |
| Novartis | 3 | $39 |
| Bayer | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| GSK | 2 | $25 |
| Abbott | 2 | $24 |
| Fisher & Paykel Healthcare Inc | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Pfizer | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$2,115 in reported general payments places this provider in the 70th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Tulsa
- Geoffrey PlumleeTulsa$297K
- Kimberly HuttonTulsa$76K
- Sarah HallTulsa$52K
- Candy TingTulsa$28K
- Scott GhereTulsa$27K
- Michael MaddoxTulsa$24K
- Randall HerbelTulsa$23K
- Chandan LadTulsa$22K
- Scott SexterTulsa$21K
- Scott KochTulsa$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.